Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Guggenheim Reiterates Buy on Endo Int'l (ENDP) Following 4Q Beat
February 28, 2017 11:45 AM ESTGuggenheim reiterated a Buy rating and $35.00 price target on Endo International plc (NASDAQ: ENDP) following the company's 4Q earnings report. ENDP reported 4Q16 adjusted EPS of $1.77, $0.14 higher than consensus. Management gave '17 EPS guidance of $3.45-$3.75, midpoint $3.60 (consensus was $4.27).
Analyst Louise Chen... More
Endo Int'l (ENDP) Tops Q4 EPS by 14c
February 28, 2017 6:31 AM ESTEndo Int'l (NASDAQ: ENDP) reported Q4 EPS of $1.77, $0.14 better than the analyst estimate of $1.63. Revenue for the quarter came in at $1.24 billion versus the consensus estimate of $1.16 billion.
For earnings history and earnings-related data on Endo Int'l (ENDP) click here.
... More